We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Self-Medicating with Herbal Cannabis Leads to Poor Mental Health

By HospiMedica International staff writers
Posted on 03 Jul 2012
A new study suggests that fibromyalgia (FM) patients that use marijuana for medicinal relief from symptomatic widespread pain, fatigue, and insomnia suffer from poorer mental health.

Researchers at McGill University Health Center (MUHC; Montreal, Canada) documented self-reported cannabinoid use in 457 FM patients. More...
FM diagnosis was validated, and associations and trends of self-medicating with medical marijuana or Cannabis, prescription cannabinoids, or both, were investigated. Patient pain levels were measured using the visual analog scale (VAS), functional ability was assessed with the Fibromyalgia Impact Questionnaire (FIQ), and a psychologist evaluated all FM participants for prior or current psychiatric conditions according to the Diagnostics and Statistical Manual of Mental Disorder (DSM-IV).

After FM diagnosis was confirmed in 302 participants, the other 155 patients were assigned another primary diagnosis (non-FM group), as controls. The researchers determined that 13% of all 457 participants used cannabinoids, with 80% using herbal Cannabis or marijuana; one third of all males used cannabinoids. Analysis found that 24% of cannabinoid users used prescription cannabinoids such as nabilone and dronabinol, and 3% were both herbal Cannabis and prescription cannabinoid users. Those smoking marijuana consumed up to 6 grams, with 72% reporting use of one gram or less per day.

The researchers determined that herbal Cannabis use was associated with unstable mental illness, opioid drug-seeking behavior, and male gender at 36%, 17%, and 26%, respectively compared to 23 %, 4%, and 7% for nonusers. A 77% unemployment rate was identified in herbal marijuana users, which the researchers believe may be due to ineffective pain control to improve functionality or a more serious functional disability. The study was published in the June 2012 issue of Arthritis Care & Research.

“While self-medicating with cannabinoids may provide some pain relief to FM patients, we caution against general use of illicit drugs until health and psychosocial issues risks are confirmed,” said lead author Prof. Mary-Ann Fitzcharles, MD. “Physicians should be alert to potential negative mental health issues in FM patients using illicit drugs for medical purposes. Some herbal Cannabis users may be dishonestly using a FM diagnosis to justify self-medicating with illegal drugs.”

Fibromyalgia is a common syndrome of chronic widespread soft-tissue pain accompanied by weakness, fatigue, and sleep disturbances; the cause is unknown, but FM is often seen as a rheumatic condition causing joint and soft tissue pain.

Related Links:

McGill University Health Center



New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Hypodermic Syringe
SurTract™ Safety Syringe
New
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Six-month FlexPulse IDE data show positive outcomes with Abbott’s TactiFlex Duo catheter, confirming safety and efficacy seen in the CE Mark study for complex AFib (photo courtesy of Abbott)

Dual-Energy Ablation and Conduction System Pacing Show Positive Early Outcomes

Atrial fibrillation and other arrhythmias are common in both hospitalized and ambulatory patients, often complicating hemodynamic stability, stroke prevention, and perioperative care. Within this context,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.